Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the World Futures Forum and the 311 Institute, a global Futures and Deep Futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future” series. Regularly featured in the global media, including AP, BBC, Bloomberg, CNBC, Discovery, RT, Viacom, and WIRED, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Aon, Bain & Co, BCG, Credit Suisse, Dell EMC, Dentons, Deloitte, E&Y, GEMS, Huawei, JPMorgan Chase, KPMG, Lego, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, T-Mobile, and many more.
WHY THIS MATTERS IN BRIEF
- Unravelling the mysteries of aging requires a multi-disciplinary approach, but as scientists gather more evidence the possibility of slowing, or reversing aging becomes more of a reality
Mitochondria — the structures within cells mostly known for converting nutrients into usable energy — may play a larger and more direct role in the aging process than previously thought, according to University of Southern California Leonard Davis School of Gerontology Assistant Professor David Lee.
In addition to powering cells, mitochondria serve important roles in coordinating metabolism, Lee said. And evidence has shown that mitochondria — which have their own smaller genome separate from the larger collection of genes in a cell’s nucleus — lose function and experience DNA damage during the aging process, reflecting a role in aging.
In trying to determine how the mitochondria are involved in ageing, many researchers have studied the signals sent from the nucleus to the mitochondria and how they change with age. However, Lee theorises that the communication between the cell’s powerhouse and its control center may be taking place in both directions, with signalling molecules originally coded in the mitochondrial DNA regulating the cells nucleus and causing changes that affect some of the key cellular factors of ageing, such as metabolism.
“Despite the fact we have two genomes — one in the nucleus and one in mitochondria — most of the focus has been put on the cells ‘nuclear’ genome. Mitochondrial signalling has emerged as a key regulator of aging, but the signals that have been described to date are not encoded in the mitochondrial genome,” Lee said.
“This cellular coordination requires communication, and some of the messengers may be encoded in the mitochondrial genome — we are trying to explore the mitochondrial genome to see how the two communicate and how that will influence the regulation of aging.”
Supported by a newly announced Junior Faculty Grant from the American Federation for Aging Research (AFAR), Lee hopes to determine the age dependent impact of MOTS-c on metabolic aging in mice, including physical performance. His findings will hopefully illuminate the roles mitochondria play in the regulation of ageing metabolism and lead to new therapies for age-related diseases.
On receiving the $100,000 grant, Lee said, “AFAR has been a major advocate and sponsor for aging research and is a pillar of the aging field that nurtured countless discoveries. AFAR is my laboratory’s mitochondria that supports the evolution of our research — it powers our laboratory in various ways.”